Jilin Province Huinan Changlong Bio-pharmacy Company Limited

SEHK:8049 Stock Report

Market Cap: HK$918.8m

Jilin Province Huinan Changlong Bio-pharmacy Balance Sheet Health

Financial Health criteria checks 5/6

Jilin Province Huinan Changlong Bio-pharmacy has a total shareholder equity of CN¥1.5B and total debt of CN¥80.4M, which brings its debt-to-equity ratio to 5.4%. Its total assets and total liabilities are CN¥2.3B and CN¥838.4M respectively. Jilin Province Huinan Changlong Bio-pharmacy's EBIT is CN¥160.6M making its interest coverage ratio -4.9. It has cash and short-term investments of CN¥658.1M.

Key information

5.4%

Debt to equity ratio

CN¥80.40m

Debt

Interest coverage ratio-4.9x
CashCN¥658.06m
EquityCN¥1.48b
Total liabilitiesCN¥838.44m
Total assetsCN¥2.32b

Recent financial health updates

No updates

Recent updates

There May Be Reason For Hope In Jilin Province Huinan Changlong Bio-pharmacy's (HKG:8049) Disappointing Earnings

Apr 04
There May Be Reason For Hope In Jilin Province Huinan Changlong Bio-pharmacy's (HKG:8049) Disappointing Earnings

With EPS Growth And More, Jilin Province Huinan Changlong Bio-pharmacy (HKG:8049) Makes An Interesting Case

Mar 26
With EPS Growth And More, Jilin Province Huinan Changlong Bio-pharmacy (HKG:8049) Makes An Interesting Case

Investors Don't See Light At End Of Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) Tunnel

Dec 27
Investors Don't See Light At End Of Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) Tunnel

With EPS Growth And More, Jilin Province Huinan Changlong Bio-pharmacy (HKG:8049) Makes An Interesting Case

Jul 12
With EPS Growth And More, Jilin Province Huinan Changlong Bio-pharmacy (HKG:8049) Makes An Interesting Case

It's Unlikely That Shareholders Will Increase Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) Compensation By Much This Year

Jun 05
It's Unlikely That Shareholders Will Increase Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) Compensation By Much This Year

How Is Jilin Province Huinan Changlong Bio-pharmacy's (HKG:8049) CEO Paid Relative To Peers?

Nov 26
How Is Jilin Province Huinan Changlong Bio-pharmacy's (HKG:8049) CEO Paid Relative To Peers?

Financial Position Analysis

Short Term Liabilities: 8049's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥725.3M).

Long Term Liabilities: 8049's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥113.2M).


Debt to Equity History and Analysis

Debt Level: 8049 has more cash than its total debt.

Reducing Debt: 8049's debt to equity ratio has increased from 0.2% to 5.4% over the past 5 years.

Debt Coverage: 8049's debt is well covered by operating cash flow (393%).

Interest Coverage: 8049 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.